Farmington, CT
Working in the comparative oncology field to study spontaneous development of glioma in Canis familiaris or dogs with emphasis on characterizing and comparing cancer genome and transcriptome to that in human glioma.
Education:
Experience:
Prof. John J. Trentin Award for Scholastic Excellence
2012 Baylor College of Medicine, Houston, TX
Blog Post
September 22, 2017
Non-invasive evaluation of molecular markers has shifted from the realm of prenatal diagnosis to tracking the effect of cancer treatment and management.
The Search Magazine Article
September 18, 2017
Professor Roel Verhaak, Ph.D., is focused on the analysis of cancer genomics data to improve our understanding of cancer biology.
In a recent PLOSOne study, a research team led by Dr. Abraham Eisenstock at the University of Missouri lays the groundwork for further developing Salmonella strains to treat prostate cancer.
Effective interpretation and identification of causative and actionable mutations in disease states is still a major hurdle to the delivery of personalized genomics.
Press Release
September 20, 2017
Mouse models for acute myeloid leukemia are available with a wide range of genetic mutations and growth profiles more closely mimic the human population.
A recent Immunity (Solmon et al, 2016) article uncovers a new combinatorial immuno-oncology approach to overcome melanoma resistance to BRAF- and immune checkpoint inhibitor single drug treatments.
A 2014 report in PLoS One describes the generation of an improved host for syngeneic tumor transplantation studies using luciferase- and EGFP-labeled tumor cells. Dubbed “Glowing Head” mice, the new models overcome several problems associated with immune responses to the bioluminescent reporters.
Learn how an enriched environment – more space, more opportunity for physical activity and social interaction – significantly slows cancer progression in mice.